SCHEMBL6925340

SCHEMBL6925340

COC(=O)c1ccc(-c2ccc(C#N)cc2)c(CBr)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 3/20 0.45
MINK1 Q8N4C8 2/20 0.45
TNIK Q9UKE5 2/20 0.45
EGLN2 Q96KS0 1/20 0.44
PLAU P00749 1/20 0.43
GSK3B P49841 1/20 0.43
EGFR P00533 1/20 0.42
ADRB2 P07550 1/20 0.41
ADRB1 P08588 1/20 0.41
ADRB3 P13945 1/20 0.41
POLB P06746 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
PTGS2 P35354 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
MRGPRX4 Q96LA9 1/20 0.41
AR P10275 1/20 0.41
XDH P47989 1/20 0.40
KDM5A P29375 1/20 0.40
KDM5B Q9UGL1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28787158 0.88 EGFR (0.52) EGFRPTGS2XDHMAPT
SCHEMBL6667541 0.85 EGLN1 (0.46) MAP4K4MINK1TNIKEGLN2GSK3B
SCHEMBL6825145 0.84 EGLN2 (0.42) MAP4K4MINK1TNIKEGLN2PLAU
SCHEMBL4707492 0.83 SLC6A4 (0.48) EGFRPTGS2XDHALDH1A1MAPT
SCHEMBL16938242 0.82 CA1 (0.50) EGFRXDHALDH1A1MAPT
SCHEMBL6924636 0.81 SLC2A1 (0.51) MAP4K4MINK1TNIKEGLN2PLAU
SCHEMBL28270387 0.81 EGFR (0.52) EGFRPTGS2MAPT
SCHEMBL5937242 0.80 NOTUM (0.47) GSK3BEGFR
SCHEMBL2428847 0.79 MAPK14 (0.52) MAP4K4MINK1TNIKEGLN2PLAU
SCHEMBL29976609 0.78 CA1 (0.44) XDHNAMPTALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004007493-A1 ARYL PIPERIDINE DERIVATIVES AS INDUCERS OF LDL-RECEPTOR EXPRESSION FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA GLAXO GROUP LIMITED (GB) 2004-01-22 WO disclosed